US Patent 10519249 Covalently linked polypeptide toxin-antibody conjugates
All edits
Edits on 3 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+353 characters)
Article
Patent abstract
Herein is reported a conjugate of a haptenylated polypeptide toxin and an anti-hapten antibody, wherein a disulfide bond is formed between a cysteine residue either before or after the lysine residue that is used for hapten-conjugation and a cysteine residue in the CDR2 of the antibody, whereby the CDR2 is determined according to Kabat.
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
105192490
Date of Patent
December 31, 2019
0Patent Application Number
152006290
Date Filed
July 1, 2016
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
105192490
Date of Patent
December 31, 2019
0Patent Application Number
152006290
Date Filed
July 1, 2016
0Patent Primary Examiner
Edits on 31 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10519249 Covalently linked polypeptide toxin-antibody conjugates
Infobox
Is a
Patent jurisdiction
Patent number
10519249
Date of patent
December 31, 2019
Patent application number
15200629
Date Filed
July 1, 2016
Patent primary examiner
Find more entities like US Patent 10519249 Covalently linked polypeptide toxin-antibody conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.